On August 26, cancer researcher Matthew Levy, Ph.D., and his lab colleagues got some unusual visitors. Young actress Abigail Breslin and 13-year-old cancer survivor Pearce Quesenberry came to visit their research lab at the Albert Einstein College of Medicine of Yeshiva University as part of Stand Up To Cancer, a national effort to raise cancer awareness and fund research.
In an important finding published online in “Developmental Cell,” researchers at Albert Einstein College of Medicine of Yeshiva University, along with collaborators at Massachusetts Institute of Technology, have identified a protein likely responsible for causing breast cancer to spread.
The deadliest part of the cancer process, metastasis, appears to rely on help from macrophages, potent immune system cells that usually defend vigorously against disease, researchers at Albert Einstein College of Medicine of Yeshiva University report.
The American Cancer Society, the nation’s largest non-governmental funder of cancer research, has given its highest award, the Medal of Honor, to four Americans who have made outstanding contributions to the fight against cancer. Among the honorees is Susan Band Horwitz, Ph.D., distinguished professor and co-chair of the Department of Molecular Pharmacology at Albert Einstein College of Medicine of Yeshiva University, who is recognized for her groundbreaking research on the cancer drug Taxol (paclitaxel), which has been used by more than 1 million patients around the world to treat cancers of the ovary, breast and lung.
Yeshiva College and Stern College for Women professors will tackle male infertility, breast cancer, and supercritical fluids as recipients of three substantial science grants totaling close to half a million dollars.
Marilyn and Stanley M. Katz, longtime benefactors of Albert Einstein College of Medicine, are donating $7 million to start a major new research program within the medical college’s Cancer Center.
Researchers at the Albert Einstein College of Medicine of Yeshiva University have received a $2 million grant from the National Cancer Institute to study tumor “microenvironments” — where tumors interact with surrounding tissues, cells and chemicals in ways that all too often encourage cancer cells to invade other areas of the body in the process known as metastasis.